Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
No data.
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study conducted prior to the establishment of standardised guidelines.

Data source

Reference
Reference Type:
secondary source
Title:
Unnamed
Year:
2008

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Principles of method if other than guideline:
For the initial induction, guinea pigs were administered hydroxylammonium sulphate (5%, in water) via intradermal injection. At day 7, animals were administered a topical induction of 25% of the test substance in water followed by a challenge treatment of 10% of the test substance in water at dat 21. At day 55, rechallenge was conducted.
GLP compliance:
not specified
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Reference substance name:
Hydroxylamine sulphate
IUPAC Name:
Hydroxylamine sulphate
Details on test material:
Purity > 98%

In vivo test system

Test animals

Species:
guinea pig
Strain:
not specified
Sex:
not specified
Details on test animals and environmental conditions:
No data

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
water
Concentration / amount:
Induction
Intradermal injection: 5% concentration of hydroxylammonium sulphate in water
Topical induction: 25% of hydroxylamonium sulphate in water

Challenge
10% hydroxylammonium sulphate
Challengeopen allclose all
Route:
other: Epicutaneous (occlusivity not stated)
Vehicle:
water
Concentration / amount:
Induction
Intradermal injection: 5% concentration of hydroxylammonium sulphate in water
Topical induction: 25% of hydroxylamonium sulphate in water

Challenge
10% hydroxylammonium sulphate
No. of animals per dose:
24 animals
Details on study design:
For the initial induction, guinea pigs were administered hydroxylammonium sulphate (5%, in water) via intradermal injection. At day 7, animals were administered a topical induction of 25% of the test substance in water followed by a challenge treatment of 10% of the test substance in water at dat 21. At day 55, rechallenge was conducted.
Challenge controls:
Control animals were administered only vehicle during the intradermal and topical induction. At the challenge, 10% of the test substance in water was administered.
Positive control substance(s):
not specified

Results and discussion

Positive control results:
No data

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Group:
test chemical
Dose level:
10%
No. with + reactions:
22
Total no. in group:
24
Clinical observations:
moderate to intense redness and swelling
Remarks on result:
other: Reading: 1st reading. Group: test group. Dose level: 10%. No with. + reactions: 22.0. Total no. in groups: 24.0. Clinical observations: moderate to intense redness and swelling.
Reading:
2nd reading
Hours after challenge:
55
Group:
test chemical
Dose level:
10%
No. with + reactions:
22
Total no. in group:
24
Clinical observations:
moderate to intense redness and swelling
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 55.0. Group: test group. Dose level: 10%. No with. + reactions: 22.0. Total no. in groups: 24.0. Clinical observations: moderate to intense redness and swelling.
Reading:
1st reading
Group:
negative control
Dose level:
10%
No. with + reactions:
0
Total no. in group:
24
Clinical observations:
No dermal reactions were observed
Remarks on result:
other: Reading: 1st reading. Group: negative control. Dose level: 10%. No with. + reactions: 0.0. Total no. in groups: 24.0. Clinical observations: No dermal reactions were observed.

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information Criteria used for interpretation of results: expert judgment
Conclusions:
Bis(hydroxylammonium)sulphate was shown to cause sensitisation reactions in guinea pigs.
Executive summary:

In Magnusson Kligman Test, similar to OECD Guideline 406, bis(hydroxylammonium)sulphate was administered to guinea pigs via intradermal injection on day 1 and topical application on day 7 as part of the induction period. Animals were challenged with the chemical on days 21 and 55 which caused sensitisation in 96% of the animals. Dermal reactions were classified into grade 2/3 (moderate to intense redness and swelling). By this study design in guinea pigs bis(hyroxylammonium)sulphate is considered to be a sensitising agent. This study is considered to be reliable with restrictions as the study was conducted prior to the establishment of standardised guidelines.